Development of PET molecular targeting agents with gallium-68

Radiochimica Acta

Volumn 99, Issue 10, 2011, Pages 641-651

  Cutler, C S ^a   Sisay, N ^a   Cantorias, M ^a   Galazzi, F ^b   Quinn, T P ^b   Smith, C J ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

DOTA; Gallium 68; NOTA; Polyaminocarboxylate ligands

Indexed keywords

EID: 80053182794     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2011.1887     Document Type: Article

References (25)

1. 67Ga citrate. J. Nucl. Med. 10, 103 (1969).
2. Gunasekera, S., King, L., Lavender, P.: The behaviour of tracer gallium-67 towards serum proteins. Clin. Chim. Acta 39, 401-406 (1972).
3. Hoffer, P. B.: Use of gallium-67 for detection of inflammatory diseases: a brief review of mechanisms and clinical applications. Nucl. Med. Biol. 8, 243-247 (1981). (Pubitemid 12162664)
4. Mintun, M. A., Dennis, D. R., Welch, M. W., Mathias, C. J., Schuster, D. P.: Measurements of pulmonary vascular permeability with PET and gallium-68 transferrin. J. Nucl. Med. 28, 1704-1716 (1987). (Pubitemid 17160289)
5. Harris, W., Pecoraro, V.: Thermodynamic binding constants for gallium tranferrin. Biochemistry 22, 292-299 (1983).
6. Green, M. A., Welch, M. J., Matthias, C. J., Fox, K. A. A., Knabb, R. M., Huffman, J. C: Gallium-68 1, 1, 1-tris (5-methoxysalicylaldiminomethyl) ethane: a potential tracer for evlauation of regional myocardial blood flow. J. Nucl. Med. 26, 170-180 (1985). (Pubitemid 16213408)
7. +. J. Nucl. Med. 34, 1127-1131 (1993). (Pubitemid 23191329)
8. Green, M. A., Mathias, C. J., Neumann, W. L., Fanwick, P. E., Janik, M., Deutsch, E. A.: Potential gallium-68 tracers for imaging the heart with PET: evaluation of four gallium complexes with functionalized tripodal tris (salicylaldimine) ligands. J. Nucl. Med. 34, 228-233 (1993). (Pubitemid 23056401)
9. Tsang, B. W., Mathias, C. J., Fanwick, P. E., Green, M. A.: Structure-distribution relationships for metal-labeled myocardial imaging agents: comparison of a series of cationic gallium (III) complexes with hexadentate bis (salicylaldimine) ligands. J. Med. Chem. 37, 4400-4406 (1994).
10. 68Ga BAPEN kit for myocardial positron emission tomography imaging and biodistribution study. Nucl. Med. Biol. 37, 149-155 (2010).
11. Kung, H. F., Liu, B. F., Mankoff, D., Kung, M. P., Billings, J. J., Francesconi, L., Alavi, A.: A new myocardial imaging agent: synthesis, characterization, and biodistribution of gallium-68-BAT-TECH. J. Nucl. Med. 31, 1635-1640 (1990). (Pubitemid 20347045)
12. Francesconi, L. C., Liu, B. L., Billings, J. J., Carroll, P. J., Graczyk, G., Kung, H. F.: Synthesis, characterization and solid structure of a neutral gallium (III) amino thiolate complex: a potential radiopharmaceutical for PET imaging. J. Chem. Soc. Chem. Commun. 94-95 (1991).
13. 68Ga THM2BED: a potential generator produced tracer of myocardial perfusion for positron emission tomography. Nucl. Med. Biol. 19, 431 (1992).
14. Govindaswamy, N., Quarless, D., Koch, S.: New amine trithiolate tripod ligand and its iron (II) and iron (III) complexes. J. Am. Chem. Soc. 117, 8468-8469 (1995).
15. Cutler, C. S., Giron, M. C., Reichert, D. E., Snyder, A. Z., Herrero, P., Anderson, C. J., Quarless, D. A., Koch, S. A., Martell, A. E., Welch, M. J.: Evaluation of gallium-68-tris (2-mercaptobenzyl) amine: a complex with brain and myocardial uptake. Nucl. Med. Biol. 26, 305-316 (1999). (Pubitemid 29179874)
16. Luyt, L. G., Katzenellenbogen, J. A.: A trithiolate tripodal bifunctional ligand for the radiolabeling of peptides with gallium (III). Bioconjug. Chem. 13, 1140-1145 (2002).
17. Brechbiel, M.: Bifunctional chelates for metal nuclides. Q. J. Nucl. Med. Mol. Imaging 52, 166-173 (2008). (Pubitemid 351721937)
18. 2] targeting vector for positron-emission tomography imaging of gastrinreleasing peptide receptor-expressing tissues. Proc. Natl. Acad. Sci. USA 104, 12462-12467 (2007). (Pubitemid 47206160)
19. 2]: a site-directed radiopharmaceutical for positron emission tomography of T-47D human breast cancer tumors. Nucl. Med. Biol. 36, 171-181 (2009).
20. Smith-Jones, P. M., Stolz, B., Bruns, C., Albert, R., Reist, H. W., Fridrich, R., Mäcke, H. R.: Gallium-67/gallium-68-[DFO]-octreotide - a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. J. Nucl. Med. 35, 317-325 (1994). (Pubitemid 24048322)
21. 67Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumors. Horm. Metab. Res. 26, 453-459 (1994).
22. Mäcke, H., Heppeler, A., Nock, B.: Somatostatin analogues labeled with different radionuclides. In: Proceedings of the Fifth International Symposium on Technetium in Chemistry and Nuclear Medicine, Bressanone, Italy, 6-9 September 1998 (Mazzi Nicolini, U., ed.), SGE Ditoriali (1999), pp. 77-91.
23. Giblin, M. F., Wang, N. N., Hoffman, T. J., Jurisson, S. S., Quinn, T. P.: Design and characterization of a-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination. Proc. Natl. Acad. Sci. USA 95, 12814-12818 (1998). (Pubitemid 28509480)
24. 188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy. Int. J. Cancer 2002, 480-487 (2002).
25. 68Ga-labeled DOTA-rheniumcyclized α-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors. Nucl. Med. Biol. 36, 505-513 (2009).